CPDA-1 155 mg/70mL

CPDA-1 155 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, aiding in blood storage and transfusion safety.

CPDA-1 155 mg/70mL is primarily used to prevent blood clotting during storage. This anticoagulant citrate phosphate dextrose adenine solution is designed for use in blood banks and medical facilities to extend the shelf life of blood products. It is commonly used in the preservation of whole blood and red blood cells for transfusion purposes.

The primary effect of CPDA-1 155 mg/70mL is to inhibit clotting by binding calcium ions. This solution also provides nutrients to maintain the viability of blood cells during storage. Users may notice the solution's clear appearance and typical anticoagulant properties when administered intravenously.

CPDA-1 155 mg/70mL should be handled with care to avoid contamination. It is essential to follow proper storage guidelines and use sterile techniques when preparing and administering the solution. Always check the solution for any signs of particulate matter or discoloration before use.

CPDA-1 155 mg/70mL may interact with certain medications or substances that affect blood clotting. It is important to consult with a healthcare provider before using this solution, especially if you are taking other anticoagulants or have any underlying medical conditions.